Gerstner Philanthropies focuses on biomedical research, educational opportunities, and assistance for people who have suffered a temporary setback and could use a “helping hand” to restore their equilibrium.

Our Biomedical Research funding falls into two categories:

  • Supporting important genomic research that could lead to breakthroughs in clinical practice
  • Enabling talented young scientists to pursue a career in research

Our Education work supports students who have talent and determination but whose opportunity to excel is limited because of their economic circumstances.

Our Helping Hands program provides assistance for people experiencing an unforeseen emergency through one-time cash grants.

In addition, we make a small number of grants related to or outside of these areas of focus.

News


  • MSK Recognizes 2021 Gerstner Sloan Kettering (GSK) Graduates During Virtual Commencement

    During a virtual commencement ceremony on Wednesday, May 19, 2021, at 3:00 pm et, Memorial Sloan Kettering Cancer Center (MSK) recognized seven Gerstner Sloan Kettering (GSK) 2021 graduates and honor Joan Argetsinger Steitz, PhD, Sterling Professor of Molecular Biophysics and Biochemistry at Yale School of Medicine and a Howard Hughes Medical Institute Investigator, with the 2021 Honorary Degree and the Memorial Sloan Kettering Medal for Outstanding Contributions to Biomedical Research. Established in 2004 with a landmark gift from Louis V. Gerstner, Jr., member of the MSK Boards of Trustees and Governing Trustees and chairman of the board of GSK, GSK admitted its first class in the summer of 2006. The school offers the next generation of biomedical scientists an intensive PhD program that trains them to investigate and attack cancer through the twin lenses of basic research and real-life clinical challenges.

    Read more at newswise.com
  • Louis V. Gerstner, Jr. to Conclude 8 Year Term as Chair of Broad Institute Board

    The Broad Institute of MIT and Harvard announced today that renowned technologist, entrepreneur and philanthropist Eric Schmidt will become the next Chair of the Board of Directors, succeeding Louis V. Gerstner, Jr., who has served as Chair of the Board since 2013. Under his leadership as Chair, the Broad Institute has expanded its focus and impact around mental illness, genome editing, cancer diagnostics, therapeutics and drug discovery, developing software tools to drive the intersection of biology and machine learning, COVID-19 testing and research to serve public health needs, and more.

    Read more at broadinstitute.org
View More News

About Us


Learn more about us.

Learn More

Reflections on Helping Hands


Lou Gerstner shares the origin of and his vision for the emergency grants program, lessons learned over the past decade, and his belief in the critical importance of the work.

Watch the video